Candriam S.C.A. Buys 15,560 Shares of Credicorp Ltd. $BAP

Candriam S.C.A. grew its stake in shares of Credicorp Ltd. (NYSE:BAP) by 29.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 68,360 shares of the bank’s stock after buying an additional 15,560 shares during the period. Candriam S.C.A. owned 0.09% of Credicorp worth $15,280,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of BAP. SVB Wealth LLC purchased a new position in Credicorp during the first quarter valued at approximately $35,000. Cullen Frost Bankers Inc. bought a new position in Credicorp in the 1st quarter valued at $40,000. First Horizon Advisors Inc. grew its position in shares of Credicorp by 33.5% during the 2nd quarter. First Horizon Advisors Inc. now owns 283 shares of the bank’s stock valued at $63,000 after purchasing an additional 71 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in shares of Credicorp during the 1st quarter valued at $78,000. Finally, Advisors Asset Management Inc. bought a new position in shares of Credicorp in the first quarter worth $88,000. 89.81% of the stock is owned by hedge funds and other institutional investors.

Credicorp Price Performance

BAP stock opened at $252.30 on Friday. The firm has a market cap of $20.07 billion, a P/E ratio of 11.96, a P/E/G ratio of 0.71 and a beta of 1.09. The firm’s fifty day moving average is $261.06 and its 200 day moving average is $237.75. Credicorp Ltd. has a 52 week low of $165.51 and a 52 week high of $280.88. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.08 and a current ratio of 1.08.

Credicorp (NYSE:BAP) last posted its quarterly earnings results on Thursday, November 13th. The bank reported $6.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.05 by $0.12. Credicorp had a net margin of 23.22% and a return on equity of 17.94%. Research analysts predict that Credicorp Ltd. will post 21.9 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms recently commented on BAP. HSBC cut Credicorp from a “buy” rating to a “hold” rating and boosted their target price for the stock from $225.00 to $255.00 in a research report on Friday, September 5th. Weiss Ratings reissued a “buy (b+)” rating on shares of Credicorp in a report on Tuesday, October 14th. The Goldman Sachs Group raised shares of Credicorp from a “sell” rating to a “neutral” rating and raised their target price for the company from $174.00 to $225.00 in a research note on Thursday, July 24th. UBS Group lifted their target price on shares of Credicorp from $257.00 to $318.00 and gave the company a “buy” rating in a research report on Tuesday, September 16th. Finally, Wall Street Zen raised shares of Credicorp from a “hold” rating to a “buy” rating in a report on Friday, August 22nd. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $256.20.

Credicorp Company Profile

Credicorp Ltd. provides various financial, insurance, and health services and products primarily in Peru and internationally. It operates through Universal Banking, Insurance and Pensions, Microfinance, and Investment Banking and Equity Management segments. The Universal Banking segment grants various credits and financial instruments to individuals and legal entities; and various deposits and current accounts.